BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 8961279)

  • 1. Mutations to forskolin resistance result in loss of adrenocorticotropin receptors and consequent reductions in levels of G protein alpha-subunits.
    Qiu R; Tsao J; Kwan WK; Schimmer BP
    Mol Endocrinol; 1996 Dec; 10(12):1708-18. PubMed ID: 8961279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocorticotropin-resistant mutants of the Y1 adrenal cell line fail to express the adrenocorticotropin receptor.
    Schimmer BP; Kwan WK; Tsao J; Qiu R
    J Cell Physiol; 1995 Apr; 163(1):164-71. PubMed ID: 7896893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of adenylyl cyclase-4 (AC-4) in Y1 and forskolin-resistant adrenal cells.
    Rui X; Al-Hakim A; Tsao J; Albert PR; Schimmer BP
    Mol Cell Endocrinol; 2004 Feb; 215(1-2):101-8. PubMed ID: 15026181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for guanyl nucleotide-binding regulatory protein beta- and gamma-subunits in the expression of the adrenocorticotropin receptor.
    Qiu R; Frigeri C; Schimmer BP
    Mol Endocrinol; 1998 Dec; 12(12):1879-87. PubMed ID: 9849962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased levels of guanyl nucleotide-binding regulatory protein alpha-subunits in Y1 adrenocortical tumor cell mutants resistant to forskolin.
    Schimmer BP; Tsao J
    Mol Endocrinol; 1990 Nov; 4(11):1698-703. PubMed ID: 1704099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective guanyl nucleotide-binding protein beta gamma subunits in a forskolin-resistant mutant of the Y1 adrenocortical cell line.
    Mitchell J; Northup JK; Schimmer BP
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8933-7. PubMed ID: 1409589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forskolin-resistant Y1 mutants harbor defects associated with the guanyl nucleotide-binding regulatory protein, Gs.
    Schimmer BP; Tsao J; Borenstein R; Endrenyi L
    J Biol Chem; 1987 Nov; 262(32):15521-6. PubMed ID: 2824464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACTH-receptor deficient mutants of the Y1 mouse adrenocortical tumor cell line.
    Schimmer BP; Kwan WK; Tsao J; Qiu R
    Endocr Res; 1995; 21(1-2):139-56. PubMed ID: 7588376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous desensitization of the human dopamine D1 receptor in Y1 adrenal cells and in a desensitization-resistant Y1 mutant.
    Olson MF; Schimmer BP
    Mol Endocrinol; 1992 Jul; 6(7):1095-102. PubMed ID: 1354841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of adenylyl cyclase activity by beta-adrenergic agonists in a desensitization-resistant mutant cell line.
    Olson MF; Tsao J; Pon DJ; Schimmer BP
    Mol Endocrinol; 1991 Jan; 5(1):34-41. PubMed ID: 1850109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forskolin-resistant Y1 adrenal cell mutants are deficient in adenylyl cyclase type 4.
    Al-Hakim A; Rui X; Tsao J; Albert PR; Schimmer BP
    Mol Cell Endocrinol; 2004 Feb; 214(1-2):155-65. PubMed ID: 15062554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the mutation to forskolin-resistance in Y1 adrenocortical tumor cells.
    Schimmer BP; Tsao J; Collie G; Wong M; Schulz P
    Endocr Res; 1984-1985; 10(3-4):365-86. PubMed ID: 6100248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired beta-adrenergic signaling pathway in white adipocytes of suckling fa/fa Zucker rats: a defect in receptor coupling.
    Mory G; Wiel M; Adli H; Diot-Dupuy F; Ferré P; Bazin R
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1592-8. PubMed ID: 11753576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The causal relationship between mutations in cAMP-dependent protein kinase and the loss of adrenocorticotropin-regulated adrenocortical functions.
    Wong M; Krolczyk AJ; Schimmer BP
    Mol Endocrinol; 1992 Oct; 6(10):1614-24. PubMed ID: 1333050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the shuttle model for Gs alpha activation of adenylyl cyclase.
    Krumins AM; Lapeyre JN; Clark RB; Barber R
    Biochem Pharmacol; 1997 Jul; 54(1):43-59. PubMed ID: 9296350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of calmodulin in the responses to adrenocorticotropin of plasma membranes from adrenal cells.
    Papadopoulos V; Widmaier EP; Hall PF
    Endocrinology; 1990 May; 126(5):2465-73. PubMed ID: 2158426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenoceptor-G protein-adenylate cyclase complex in rat hearts with ischemic heart failure produced by coronary artery ligation.
    Yamamoto J; Ohyanagi M; Morita M; Iwasaki T
    J Mol Cell Cardiol; 1994 May; 26(5):617-26. PubMed ID: 8072016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered G protein activity in a desensitization-resistant mutant of the Y1 adrenocortical tumor cell line.
    Colantonio CM; Kwan WK; Czerwinski W; Mitchell J; Schimmer BP
    Endocrinology; 1998 Feb; 139(2):626-33. PubMed ID: 9449634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACTH receptor: ectopic expression, activity and signaling.
    Forti FL; Dias MH; Armelin HA
    Mol Cell Biochem; 2006 Dec; 293(1-2):147-60. PubMed ID: 16845490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.